Deprenyl, a therapeutic agent for Parkinson's disease, inhibits arsenic toxicity potentiated by GSH depletion via inhibition of JNK activation (Q45129788)
Jump to navigation
Jump to search
scientific article published in December 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Deprenyl, a therapeutic agent for Parkinson's disease, inhibits arsenic toxicity potentiated by GSH depletion via inhibition of JNK activation |
scientific article published in December 2004 |
Statements
1 reference
Deprenyl, a therapeutic agent for Parkinson's disease, inhibits arsenic toxicity potentiated by GSH depletion via inhibition of JNK activation (English)
1 reference
Sang Geon Kim
1 reference
Chang Ho Lee
1 reference
Jeong Weon Park
1 reference
1 December 2004
1 reference
1 reference
67
1 reference
23-24
1 reference
2013-2024
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference